CU Medical Systems Statistics

Total Valuation

CU Medical Systems has a market cap or net worth of KRW 41.64 billion. The enterprise value is 66.81 billion.

Market Cap	41.64B
Enterprise Value	66.81B

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

CU Medical Systems has 60.52 million shares outstanding. The number of shares has increased by 2.09% in one year.

Current Share Class	n/a
Shares Outstanding	60.52M
Shares Change (YoY)	+2.09%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	29.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.87
PB Ratio	0.60
P/TBV Ratio	0.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.04, with an EV/FCF ratio of -10.91.

EV / Earnings	-8.53
EV / Sales	1.76
EV / EBITDA	11.04
EV / EBIT	18.15
EV / FCF	-10.91

Financial Position

The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.67.

Current Ratio	2.56
Quick Ratio	1.79
Debt / Equity	0.67
Debt / EBITDA	6.22
Debt / FCF	-6.15
Interest Coverage	4.15

Financial Efficiency

Return on equity (ROE) is -13.11% and return on invested capital (ROIC) is 2.55%.

Return on Equity (ROE)	-13.11%
Return on Assets (ROA)	2.34%
Return on Capital (ROIC)	2.55%
Revenue Per Employee	305.96M
Profits Per Employee	-63.16M
Employee Count	124
Asset Turnover	0.39
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.91%
50-Day Moving Average	693.66
200-Day Moving Average	731.18
Relative Strength Index (RSI)	59.10
Average Volume (20 Days)	83,662

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CU Medical Systems had revenue of KRW 37.94 billion and -7.83 billion in losses. Loss per share was -162.75.

Revenue	37.94B
Gross Profit	19.48B
Operating Income	3.68B
Pretax Income	-7.43B
Net Income	-7.83B
EBITDA	6.05B
EBIT	3.68B
Loss Per Share	-162.75

Full Income Statement

Balance Sheet

The company has 13.01 billion in cash and 37.65 billion in debt, giving a net cash position of -24.65 billion or -407.20 per share.

Cash & Cash Equivalents	13.01B
Total Debt	37.65B
Net Cash	-24.65B
Net Cash Per Share	-407.20
Equity (Book Value)	56.05B
Book Value Per Share	1,153.87
Working Capital	18.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.21 billion and capital expenditures -20.33 billion, giving a free cash flow of -6.12 billion.

Operating Cash Flow	14.21B
Capital Expenditures	-20.33B
Free Cash Flow	-6.12B
FCF Per Share	-101.20

Full Cash Flow Statement

Margins

Gross margin is 51.36%, with operating and profit margins of 9.70% and -20.64%.

Gross Margin	51.36%
Operating Margin	9.70%
Pretax Margin	-19.58%
Profit Margin	-20.64%
EBITDA Margin	15.95%
EBIT Margin	9.70%
FCF Margin	n/a

Dividends & Yields

CU Medical Systems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.09%
Shareholder Yield	-2.09%
Earnings Yield	-23.66%
FCF Yield	-14.71%

Stock Splits

The last stock split was on April 12, 2016. It was a forward split with a ratio of 2.

Last Split Date	Apr 12, 2016
Split Type	Forward
Split Ratio	2

Scores

CU Medical Systems has an Altman Z-Score of 0.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.81
Piotroski F-Score	n/a